Home Neurosolv Therapeutics

Neurosolv Therapeutics

In operation
Undisclosed
Spinal Cord Injury Therapy Developer
Basic
Enterprise Profile

Basic Information

Neurosolve Therapeutics, an ethical enterprise headquartered in Belfast, Northern Ireland, and Baltimore, USA, has developed and patented Perineline™ to address spinal cord injuries. Glial scarring remains in the spinal cord after injury, blocking nerve signals transmitted to the body. Perineline™, a two-part treatment, allows signals to pass through the treated area, enabling functional recovery for the body and patients.
Neurosolv Therapeutics
Belfast,NorthernIreland,United Kingdom
unclear
--
aidan.lynch@neurosolvtherapeutics.com

Enterprise Profile

Industrial Sector
New Drug Development
Technology
Biotechnology
Application Scenarios
Innovative Drugs